Gilgamesh Pharmaceuticals

0 followers


Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy.

Industries

Headquarters

Employees

Links

Org chart

Jonathan Sporn
CEO & Co-Founder

Jonathan Sporn

Collapse
Dalibor Sames
Co-founder
Andrew Kruegel
Chief Scientific Officer
Jeff Witkin
Preclinical Pharmacologist & Co-Founder
Jay Gingrich
Consultant
Daniel Umbricht
Head Of Clinical Development
Robert Berman
Consultant
Eric Austin
Head of Toxicology and ADME
Grace Parker
Preclinical Projects Manager
William Leong
EVP, Head of CMC
Yoni Falkson
Chief Operating Officer